The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation
Open accessAbstract
Apathy has been reported to occur after subthalamic nucleus stimulation, a treatment of motor complications in advanced Parkinson's disease. We carried out a prospective study of the occurrence of apathy and associated symptoms, predictors and mechanisms in the year following subthalamic stimulation. Dopamine agonist drugs were discontinued immediately after surgery and levodopa was markedly reduced within 2 weeks. Apathy and depression were assessed monthly, using the Starkstein apathy scale and the Beck Depression Inventory. Dopamine agonists were re-introduced if patients developed apathy or depression. Preoperative non-motor fluctuations were evaluated using the Ardouin Scale. Depression, apathy and anxiety were evaluated both on and off levodopa. Analysis of predictors of apathy was performed using a Cox proportional hazard model. Twelve patients who developed apathy and a control group of 13 patients who did not underwent [11C]-raclopride positron emission tomography scanning before and after oral intake of methylphenidate. In 63 patients with Parkinson's disease treated with subthalamic stimulation, dopaminergic treatment was decreased by 82% after surgery. Apathy occurred after a mean of 4.7 (3.3-8.2) months in 34 patients and was reversible in half of these by the 12-month follow-up. Seventeen patients developed transient depression after 5.7 (4.7-9.3) months and these fell into the apathy group with one single exception. At baseline, fluctuations in depression, apathy and anxiety scores were greater in the group with apathy. Fluctuations in apathy, depression and anxiety ratings during a baseline levodopa challenge were also significant predictors of postoperative apathy in univariate analysis, but not motor and cognitive states or the level of reduction of dopaminergic medication. The multivariate model identified non-motor fluctuations in everyday life and anxiety score during the baseline levodopa challenge as two independent significant predictors of postoperative apathy. Without methylphenidate, [11C]-raclopride binding potential values were greater in apathetic patients bilaterally in the orbitofrontal, dorsolateral prefrontal, posterior cingulate and temporal cortices, left striatum and right amygdala, reflecting greater dopamine D2/D3 receptor density and/or reduced synaptic dopamine level in these areas. The variations of [11C]-raclopride binding potential values induced by methylphenidate were greater in non-apathetic patients in the left orbitofrontal cortex, dorsolateral prefrontal cortex, thalamus and internal globus pallidus and bilaterally in the anterior and posterior cingulate cortices, consistent with a more important capacity to release dopamine. Non-motor fluctuations are related to mesolimbic dopaminergic denervation. Apathy, depression and anxiety can occur after surgery as a delayed dopamine withdrawal syndrome. A varying extent of mesolimbic dopaminergic denervation and differences in dopaminergic treatment largely determine mood, anxiety and motivation in patients with Parkinson's disease, contributing to different non-motor phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407
Statistical parametric maps in functional imaging: A general linear approach
Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients
Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6703_13 · Cited by 5,965
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P. D., Benazzouz, A., LeBas, J. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035275 · Cited by 2,249
Self-citationThe mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Levodopa and the Progression of Parkinson's Disease
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa033447 · Cited by 1,821
The Emotional Brain, Fear, and the Amygdala
LeDoux, J. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1025048802629 · Cited by 1,818
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
Chaudhuri, K. R., & Schapira, A. H. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70068-7 · Cited by 1,738
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G.-J., Ding, Y.-S., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,514
Paxinos, G., & Jürgen, K. (2004) · Cited by 1,478
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22643 · Cited by 1,445
Apathy and the Functional Anatomy of the Prefrontal Cortex–Basal Ganglia Circuits
Levy, R., & Dubois, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj043 · Cited by 1,285
Modification of Parkinsonism — Chronic Treatment with L-Dopa
Cotzias, G. C., Papavasiliou, P. S., & Gellene, R. (1969) · New England Journal of Medicine · doi:10.1056/nejm196902132800701 · Cited by 1,284
Reliability, validity, and clinical correlates of apathy in Parkinson's disease
(1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.2.134 · Cited by 1,185
Mayberg, H. S., Brannan, S. K., Tekell, J. L., Silva, J. A., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01036-2 · Cited by 1,115
Brog, J. S., Salyapongse, A., Deutch, A. Y., & Zahm, D. S. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903380209 · Cited by 1,102
Chaudhuri, K. R., Martinez‐Martin, P., Schapira, A. H. V., Stocchi, F., Sethi, K., Odin, P., Brown, R. G., Koller, W., Barone, P., MacPhee, G., et al. (2006) · Movement Disorders · doi:10.1002/mds.20844 · Cited by 1,100 · cited 1×
“While specific validated tools have been developed to assess the full spectrum of non-motor symptoms (Chaudhuri et al., 2006; Goetz et al., 2008; Chaudhuri and Schapira, 2009), fluctuations of these symptoms have only rarely been assessed (Witjas et al.”
BackgroundApathy: a neuropsychiatric syndrome
(1991) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.3.3.243 · Cited by 1,087
The behavioural and motor consequences of focal lesions of the basal ganglia in man
Bhatia, K. P., & Marsden, C. D. (1994) · Brain · doi:10.1093/brain/117.4.859 · Cited by 1,073
Remy, P., Doder, M., Lees, A., Turjanski, N., & Brooks, D. (2005) · Brain · doi:10.1093/brain/awh445 · Cited by 1,040
Imaging dopamine's role in drug abuse and addiction
Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., & Telang, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.022 · Cited by 988
Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
Kleiner-Fisman, G., Herzog, J., Fisman, D. N., Tamma, F., Lyons, K. E., Pahwa, R., Lang, A. E., & Deuschl, G. (2006) · Movement Disorders · doi:10.1002/mds.20962 · Cited by 957
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms
Rodriguez-Oroz, M. C., Jahanshahi, M., Krack, P., Litvan, I., Macias, R., Bezard, E., & Obeso, J. A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70293-5 · Cited by 863
Self-citationAmphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706
Posterior cingulate cortex activation by emotional words: fMRI evidence from a valence decision task
Maddock, R. J., Garrett, A. S., & Buonocore, M. H. (2003) · Human Brain Mapping · doi:10.1002/hbm.10075 · Cited by 695 · cited 1×
“Convergent arguments have shown that the PCC plays a critical role in the regulation of negative emotions by encoding the emotional significance of stimuli (Liotti et al., 2000; Maddock et al., 2003).”
BackgroundLevy, M. L., Cummings, J. L., Fairbanks, L. A., Masterman, D., Miller, B. L., Craig, A. H., Paulsen, J. S., & Litvan, I. (1998) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.10.3.314 · Cited by 678
Witt, K., Daniels, C., Reiff, J., Krack, P., Volkmann, J., Pinsker, M. O., Krause, M., Tronnier, V., Kloss, M., Schnitzler, A., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70114-5 · Cited by 651
Self-citationNonmotor fluctuations in Parkinson’s disease: Frequent and disabling
Witjas, T., Kaphan, E., Azulay, J. P., Blin, O., Ceccaldi, M., Pouget, J., Poncet, M., & Chérif, A. A. (2002) · Neurology · doi:10.1212/wnl.59.3.408 · Cited by 642
Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease
Krack, P. (1998) · Brain · doi:10.1093/brain/121.3.451 · Cited by 608
Self-citationTreatment of Parkinsonism With Levodopa
Yahr, M. D., Duvoisin, R. C., Schear, M. J., Barrett, R. E., & Hoehn, M. M. (1969) · Archives of Neurology · doi:10.1001/archneur.1969.00480160015001 · Cited by 604
Range of neuropsychiatric disturbances in patients with Parkinson's disease
Aarsland, D., Larsen, J. P., Lim, N. G., Janvin, C., Karlsen, K., Tandberg, E., & Cummings, J. L. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.4.492 · Cited by 581
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
Guillin, O., Diaz, J., Carroll, P., Griffon, N., Schwartz, J.-C., & Sokoloff, P. (2001) · Nature · doi:10.1038/35075076 · Cited by 574
Funkiewiez, A. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2002.009803 · Cited by 572
Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Dodd, M. L., Klos, K. J., Bower, J. H., Geda, Y. E., Josephs, K. A., & Ahlskog, J. E. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.noc50009 · Cited by 563
Saint-Cyr, J. A. (2000) · Brain · doi:10.1093/brain/123.10.2091 · Cited by 554
Quality of life in Parkinson's disease: the relative importance of the symptoms
Rahman, S., Griffin, H. J., Quinn, N. P., & Jahanshahi, M. (2008) · Movement Disorders · doi:10.1002/mds.21667 · Cited by 532
Steeves, T. D. L., Miyasaki, J., Zurowski, M., Lang, A. E., Pellecchia, G., Van Eimeren, T., Rusjan, P., Houle, S., & Strafella, A. P. (2009) · Brain · doi:10.1093/brain/awp054 · Cited by 502
Roles for nigrostriatal—not just mesocorticolimbic—dopamine in reward and addiction
Wise, R. A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.004 · Cited by 500
Behavioural disorders, Parkinson's disease and subthalamic stimulation
Houeto, J. L. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.701 · Cited by 500
Ambroggi, F., Ishikawa, A., Fields, H. L., & Nicola, S. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.004 · Cited by 495
Leyton, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00366-4 · Cited by 476
Compulsive drug use linked to sensitized ventral striatal dopamine transmission.
Evans, A. H., Pavese, N., Lawrence, A. D., Tai, Y. F., Appel, S., Doder, M., Brooks, D. J., Lees, A. J., & Piccini, P. (2006) · Annals of Neurology · doi:10.1002/ana.20822 · Cited by 473
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease
Voon, V., Krack, P., Lang, A. E., Lozano, A. M., Dujardin, K., Schüpbach, M., D’Ambrosia, J., Thobois, S., Tamma, F., Herzog, J., et al. (2008) · Brain · doi:10.1093/brain/awn214 · Cited by 472
Self-citationAnxiety disorders and depressive disorders preceding Parkinson's disease: A case-control study
Shiba, M., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2000) · Movement Disorders · doi:10.1002/1531-8257(200007)15:4<669::aid-mds1011>3.0.co;2-5 · Cited by 465
Emotion-induced changes in human medial prefrontal cortex: II. During anticipatory anxiety
Simpson, J. R., Drevets, W. C., Snyder, A. Z., Gusnard, D. A., & Raichle, M. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.688 · Cited by 438
Mallet, L., Schüpbach, M., N'Diaye, K., Remy, P., Bardinet, E., Czernecki, V., Welter, M.-L., Pelissolo, A., Ruberg, M., Agid, Y., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610849104 · Cited by 437
Liotti, M., Mayberg, H. S., Brannan, S. K., McGinnis, S., Jerabek, P., & Fox, P. T. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00874-x · Cited by 424 · cited 1×
“Convergent arguments have shown that the PCC plays a critical role in the regulation of negative emotions by encoding the emotional significance of stimuli (Liotti et al., 2000; Maddock et al., 2003).”
BackgroundIs the mesocortical dopaminergic system involved in Parkinson disease?
Javoy-Agid, F., & Agid, Y. (1980) · Neurology · doi:10.1212/wnl.30.12.1326 · Cited by 413
L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.
Barbeau, A. (1969) · PubMed · Cited by 410
Deep brain stimulation: Neuropsychological and neuropsychiatric issues
Voon, V., Kubu, C., Krack, P., Houeto, J.-L., & Tröster, A. I. (2006) · Movement Disorders · doi:10.1002/mds.20963 · Cited by 403
Self-citationThe action of sedatives on brain stem oculomotor systems in man
Norris, H. (1971) · Neuropharmacology · doi:10.1016/0028-3908(71)90039-6 · Cited by 388
The nosological position of apathy in clinical practice
Starkstein, S. E., & Leentjens, A. F. G. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.136895 · Cited by 371
Ardouin, C., Pillon, B., Peiffer, E., Bejjani, P., Limousin, P., Damier, P., Arnulf, I., Benabid, A. L., Agid, Y., & Pollak, P. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199908)46:2<217::aid-ana11>3.0.co;2-z · Cited by 366
Self-citationBodi, N., Keri, S., Nagy, H., Moustafa, A., Myers, C. E., Daw, N., Dibo, G., Takats, A., Bereczki, D., & Gluck, M. A. (2009) · Brain · doi:10.1093/brain/awp094 · Cited by 363
Motivation, reward, and Parkinson's disease: influence of dopatherapy
Czernecki, V (2002) · Neuropsychologia · doi:10.1016/s0028-3932(02)00108-2 · Cited by 338
Voon, V., Fernagut, P.-O., Wickens, J., Baunez, C., Rodriguez, M., Pavon, N., Juncos, J. L., Obeso, J. A., & Bezard, E. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70287-x · Cited by 335
Mirthful laughter induced by subthalamic nucleus stimulation
Krack, P., Kumar, R., Ardouin, C., Dowsey, P. L., McVicker, J. M., Benabid, A., & Pollak, P. (2001) · Movement Disorders · doi:10.1002/mds.1174 · Cited by 304
Self-citationNegative symptoms: the ‘pathology’ of motivation and goal-directed behaviour
Brown, R. G., & Pluck, G. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01626-x · Cited by 303
The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease
Aarsland, D., Bronnick, K., Alves, G., Tysnes, O. B., Pedersen, K. F., Ehrt, U., & Larsen, J. P. (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.166959 · Cited by 300
The behavioral spectrum of Gilles de la Tourette syndrome
Cavanna, A. E., Servo, S., Monaco, F., & Robertson, M. M. (2009) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.2009.21.1.13 · Cited by 297
Dissociating apathy and depression in Parkinson disease
Kirsch-Darrow, L., Fernandez, H. F., Marsiske, M., Okun, M. S., & Bowers, D. (2006) · Neurology · doi:10.1212/01.wnl.0000230572.07791.22 · Cited by 284
Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?
Lawrence, A. D., Evans, A. H., & Lees, A. J. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00529-5 · Cited by 282
Neuropsychological effects of bilateral STN stimulation in Parkinson disease: A controlled study
Smeding, H. M. M., Speelman, J. D., Koning-Haanstra, M., Schuurman, P. R., Nijssen, P., van Laar, T., & Schmand, B. (2006) · Neurology · doi:10.1212/01.wnl.0000234881.77830.66 · Cited by 272
Romito, L. M., Raja, M., Daniele, A., Contarino, M. F., Bentivoglio, A. R., Barbier, A., Scerrati, M., & Albanese, A. (2002) · Movement Disorders · doi:10.1002/mds.10265 · Cited by 266
Funkiewiez, A., Ardouin, C., Krack, P., Fraix, V., Van Blercom, N., Xie, J., Moro, E., Benabid, A., & Pollak, P. (2003) · Movement Disorders · doi:10.1002/mds.10441 · Cited by 264
Self-citationPathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation
Ardouin, C., Voon, V., Worbe, Y., Abouazar, N., Czernecki, V., Hosseini, H., Pelissolo, A., Moro, E., Lhommée, E., Lang, A. E., et al. (2006) · Movement Disorders · doi:10.1002/mds.21098 · Cited by 261
Self-citationDopamine dysregulation syndrome in Parkinson's disease
Evans, A. H., & Lees, A. J. (2004) · Current Opinion in Neurology · doi:10.1097/01.wco.0000137528.23126.41 · Cited by 257
Diagnosis and the premotor phase of Parkinson disease
Tolosa, E., Gaig, C., Santamaría, J., & Compta, Y. (2009) · Neurology · doi:10.1212/wnl.0b013e318198db11 · Cited by 255
Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease
Smeding, H. M. M., Goudriaan, A. E., Foncke, E. M. J., Schuurman, P. R., Speelman, J. D., & Schmand, B. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.102061 · Cited by 254
Dopamine‐related personality traits in Parkinson's disease
Menza, M. A., Golbe, L. I., Cody, R. A., & Forman, N. E. (1993) · Neurology · doi:10.1212/wnl.43.3_part_1.505 · Cited by 247
Stacy, M., Bowron, A., Guttman, M., Hauser, R., Hughes, K., Larsen, J. P., LeWitt, P., Oertel, W., Quinn, N., Sethi, K., et al. (2005) · Movement Disorders · doi:10.1002/mds.20383 · Cited by 246
Lim, S.-Y., O’Sullivan, S. S., Kotschet, K., Gallagher, D. A., Lacey, C., Lawrence, A. D., Lees, A. J., O’Sullivan, D. J., Peppard, R. F., Rodrigues, J. P., et al. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.12.010 · Cited by 240
Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation
Witjas, T., Baunez, C., Henry, J. M., Delfini, M., Regis, J., Cherif, A. A., Peragut, J. C., & Azulay, J. P. (2005) · Movement Disorders · doi:10.1002/mds.20501 · Cited by 238
Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom
Czernecki, V., Schüpbach, M., Yaici, S., Lévy, R., Bardinet, E., Yelnik, J., Dubois, B., & Agid, Y. (2008) · Movement Disorders · doi:10.1002/mds.21949 · Cited by 230
Krack, P. (1999) · Brain · doi:10.1093/brain/122.6.1133 · Cited by 229
Self-citationDoes subthalamic nucleus stimulation induce apathy in Parkinson’s disease?
Drapier, D., Drapier, S., Sauleau, P., Haegelen, C., Raoul, S., Biseul, I., Peron, J., Lallement, F., Rivier, I., Reymann, J. M., et al. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0177-0 · Cited by 221
Characteristics of apathy in Parkinson's disease
Dujardin, K., Sockeel, P., Devos, D., Delliaux, M., Krystkowiak, P., Destée, A., & Defebvre, L. (2007) · Movement Disorders · doi:10.1002/mds.21316 · Cited by 219
Conditioned cues and the expression of stimulant sensitization in animals and humans
Vezina, P., & Leyton, M. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.070 · Cited by 213
Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease
Isella, V., Melzi, P., Grimaldi, M., Iurlaro, S., Piolti, R., Ferrarese, C., Frattola, L., & Appollonio, I. (2002) · Movement Disorders · doi:10.1002/mds.10041 · Cited by 212
Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine
Schlagenhauf, F., Juckel, G., Koslowski, M., Kahnt, T., Knutson, B., Dembler, T., Kienast, T., Gallinat, J., Wrase, J., & Heinz, A. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1016-4 · Cited by 204
Disconnecting force from money: effects of basal ganglia damage on incentive motivation
Schmidt, L., d’Arc, B. F., Lafargue, G., Galanaud, D., Czernecki, V., Grabli, D., Schüpbach, M., Hartmann, A., Lévy, R., Dubois, B., et al. (2008) · Brain · doi:10.1093/brain/awn045 · Cited by 197
Prevalence and clinical correlates of apathy in Parkinson's disease: A community-based study
Pedersen, K. F., Larsen, J. P., Alves, G., & Aarsland, D. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.07.006 · Cited by 194
Migneco, O., Benoit, M., Koulibaly, P. M., Dygai, I., Bertogliati, C., Desvignes, P., Robert, P. H., Malandain, G., Bussiere, F., & Darcourt, J. (2001) · NeuroImage · doi:10.1006/nimg.2000.0741 · Cited by 192
Dopamine and impulse control disorders in Parkinson's disease
Weintraub, D. (2009) · Annals of Neurology · doi:10.1002/ana.21454 · Cited by 191
Pure psychic akinesia with bilateral lesions of basal ganglia.
Laplane, D., Baulac, M., Widlocher, D., & Dubois, B. (1984) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.47.4.377 · Cited by 191
Holthoff, V. A., Beuthien-Baumann, B., Kalbe, E., Lüdecke, S., Lenz, O., Zündorf, G., Spirling, S., Schierz, K., Winiecki, P., Sorbi, S., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.035 · Cited by 190
Orbitofrontal Dysfunction Related to Both Apathy and Disinhibition in Frontotemporal Dementia
Peters, F., Perani, D., Herholz, K., Holthoff, V., Beuthien-Baumann, B., Sorbi, S., Pupi, A., Degueldre, C., Lemaire, C., Collette, F., et al. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000091898 · Cited by 190
Subthalamic nucleus stimulation in Parkinson disease induces apathy: A PET study
Le Jeune, F., Drapier, D., Bourguignon, A., Péron, J., Mesbah, H., Drapier, S., Sauleau, P., Haegelen, C., Travers, D., Garin, E., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c34b34 · Cited by 187
Bostwick, J. M., Hecksel, K. A., Stevens, S. R., Bower, J. H., & Ahlskog, J. E. (2009) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60538-7 · Cited by 183
Dopamine in amygdala gates limbic processing of aversive stimuli in humans
Kienast, T., Hariri, A. R., Schlagenhauf, F., Wrase, J., Sterzer, P., Buchholz, H. G., Smolka, M. N., Gründer, G., Cumming, P., Kumakura, Y., et al. (2008) · Nature Neuroscience · doi:10.1038/nn.2222 · Cited by 177
The syndromal validity and nosological position of apathy in Parkinson's disease
STARKSTEIN, S. E., Merello, M., Jorge, R. E., Brockman, S., Bruce, D. G., & Power, B. (2009) · Movement Disorders · doi:10.1002/mds.22577 · Cited by 167
Lemke, M. R., Brecht, H. M., Koester, J., Kraus, P. H., & Reichmann, H. (2005) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.17.2.214 · Cited by 163
Évaluation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson
Ardouin, C., Chéreau, I., Llorca, P., Lhommée, E., Durif, F., Pollak, P., & Krack, P. (2009) · Revue Neurologique · doi:10.1016/j.neurol.2009.06.003 · Cited by 152
Self-citationSchweri, M. M., Skolnick, P., Rafferty, M. F., Rice, K. C., Janowsky, A. J., & Paul, S. M. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb05524.x · Cited by 151
Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease
Cilia, R., Siri, C., Marotta, G., Isaias, I. U., Gaspari, D. D., Canesi, M., Pezzoli, G., & Antonini, A. (2008) · Archives of Neurology · doi:10.1001/archneur.65.12.1604 · Cited by 142
Mood swings associated with the ‘on—off’ phenomenon in Parkinson's disease
Nissenbaum, H., Quinn, N. P., Brown, R. G., Toone, B., Gotham, A.-M., & MARSDEN, C. D. (1987) · Psychological Medicine · doi:10.1017/s0033291700000702 · Cited by 141
Jeune, F. L., Péron, J., Biseul, I., Fournier, S., Sauleau, P., Drapier, S., Haegelen, C., Drapier, D., Millet, B., Garin, É., et al. (2008) · Brain · doi:10.1093/brain/awn084 · Cited by 130
Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency
Tomer, R. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.024885 · Cited by 123
Levodopa-related motor complications-Phenomenology
Fox, S. H., & Lang, A. E. (2008) · Movement Disorders · doi:10.1002/mds.22021 · Cited by 119
Benoît, M., Koulibaly, P. M., Migneco, O., Darcourt, J., Pringuey, D., & Robert, P. H. (2002) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(02)00003-3 · Cited by 118
Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?
Czernecki, V. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.033258 · Cited by 118
Apathy in drug-naïve patients with incident Parkinson’s disease: the Norwegian ParkWest study
Pedersen, K. F., Alves, G. W., Brønnick, K., Aarsland, D., Tysnes, O., & Larsen, J. P. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5297-x · Cited by 96
Decreasing Striatal 6-FDOPA Uptake with Increasing Duration of Cocaine Withdrawal
Wu, J. C. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00089-4 · Cited by 94
Maricle, R. A., Nutt, J. G., & Carter, J. H. (1995) · Movement Disorders · doi:10.1002/mds.870100316 · Cited by 89
Lees, A. J. (2009) · Neurology · doi:10.1212/wnl.0b013e318198daec · Cited by 88
Patkar, A. A., Berrettini, W. H., Hoehe, M. R., Thornton, C. C., Gottheil, E., Hill, K. P., & Weinstein, S. P. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00098-7 · Cited by 87
Ulla, M., Thobois, S., Lemaire, J., Schmitt, A., Derost, P., Broussolle, E., Llorca, P., & Durif, F. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.096628 · Cited by 87
Self-citationThobois, S. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.12.003 · Cited by 86
Self-citationThobois, S., Vingerhoets, F. J. G., Fraix, V., Xie‐Brustolin, J., Mollion, H., Costes, N., Mertens, P., Benabid, A., Pollak, P., & Broussolle, E. (2004) · Archives of Neurology · doi:10.1001/archneur.61.11.1705 · Cited by 83
Self-citationResponse to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation
Moro, E., Esselink, R. A. J., Benabid, A. L., et al. (2002) · Brain · doi:10.1093/brain/awf249 · Cited by 82
Self-citationLevodopa‐induced dyskinesias in Parkinson's disease: Is sensitization reversible?
Bejjani, B.-P. W., Arnulf, I., Demeret, S., Damier, P., Bonnet, A., Houéto, J., & Agid, Y. (2000) · Annals of Neurology · Cited by 82
Fields, J. A., & Tröster, A. I. (2000) · Brain and Cognition · doi:10.1006/brcg.1999.1104 · Cited by 80
Levodopa Challenge Neuroimaging of Levodopa-Related Mood Fluctuations in Parkinson's Disease
BLACK, K. J., Hershey, T. G., Hartlein, J. M., Carl, J. L., & Perlmutter, J. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300632 · Cited by 76
Menza, M. A., Mark, M. H., Burn, D. J., & Brooks, D. J. (1995) · Journal of Neuropsychiatry · doi:10.1176/jnp.7.2.176 · Cited by 76
Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy
Stacy, M. A., Murck, H., & Kroenke, K. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.09.023 · Cited by 63
Gjedde, A., Wong, D. F., Rosa-Neto, P., & Cumming, P. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)63001-2 · Cited by 50
Effects of Methylphenidate on Response to Oral Levodopa
Nutt, J. G., Carter, J. H., & Carlson, N. E. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.319 · Cited by 34
Cognitive and limbic effects of deep brain stimulation in preclinical studies
Temel, Y., Tan, S. K. H., Vlamings, R., Sesia, T., Lim, L. W., Lardeux, S., Visser-Vandewalle, V. E. R. M., & Baunez, C. (2009) · Frontiers in bioscience · doi:10.2741/3349 · Cited by 31
Neuropsychology of deep brain stimulation in neurology and psychiatry
Alexander, I. T. (2009) · Frontiers in bioscience · doi:10.2741/3347 · Cited by 27
Manrique, C., H�ry, F., Faudon, M., & François‐Bellan, A. M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990915)33:4<268::aid-syn3>3.0.co;2-w · Cited by 25
Cited by
Neuropsychiatric symptoms in Parkinson's disease
Aarsland, D., Marsh, L., & Schrag, A. (2009) · Movement Disorders · doi:10.1002/mds.22589 · Cited by 557
Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment
Pagonabarraga, J., Kulisevsky, J., Strafella, A. P., & Krack, P. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00019-8 · Cited by 549
Self-citationPathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation
Fasano, A., Daniele, A., & Albanese, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70049-2 · Cited by 437
Parkinson's disease: The quintessential neuropsychiatric disorder
Weintraub, D., & Burn, D. J. (2011) · Movement Disorders · doi:10.1002/mds.23664 · Cited by 423
Metadata
- Authors
- Thobois, S., Ardouin, C., Lhommee, E., Klinger, H., Lagrange, C., Xie, J., Fraix, V., Coelho Braga, M. C., Hassani, R., Kistner, A., Juphard, A., Seigneuret, E., Chabardes, S., Mertens, P., Polo, G., Reilhac, A., Costes, N., LeBars, D., Savasta, M., Tremblay, L., Quesada, J. L., Bosson, J. L., Benabid, A. L., Broussolle, E., Pollak, P., & Krack, P.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-03-17
- Volume
- 133
- Issue
- 4
- Pages
- 1111-1127
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2118502552
- Cited by
- 516
- References
- 124
- FWCI
- 24.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.